Posted in | News | Ferrous Alloys and Metals | Minerals | Iron and Steel

Laiwa Steel Licence HIsmelt Technology

Sep 4 2003

Related Stories

China’s Laiwa Steel Group have signed a licence agreement to use Rio Tinto’s HIsmelt technology in an ironmaking plant to be built in China’s Shandong Province.

The proposed plant will be a replica of plant currently under construction in Kwinana, Western Australia. This plant is a joint venture between Rio Tinto, Nucor, Mitsubishi Corp and Shougang Corp.

The technology is direct smelting process that uses iron ore fines and/or other iron containing materials, as well as non-coking coals. These materials are injected into a molten bath of iron to product high quality iron. The product materials are suitable for use in electric arc furnaces, while the process offers an alternative to traditional blast furnace technology.

For more information on steel manufacture, click here.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
(Logout)
Your comment type
Submit

Sponsored Content

Editorial Highlights

The Current State of the Global Semiconductor Market

The Current State of the Global Semiconductor Market

The global semiconductor market has entered an exciting period. Demand for chip technology is both driving the industry as well as hindering it, with current chip shortages predicted to last for some time. Current trends will likely shape the future of the industry, which is set to continue to show

How are Graphene Batteries Made?

How are Graphene Batteries Made?

The primary distinction between graphene-based batteries and solid-state batteries lies in the composition of either electrode. Although the cathode is commonly changed, carbon allotropes can also be employed in fabricating anodes.

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback